Buffer

Microbix Presents Results of STI Test Controls at ASM Microbe

Retrieved on: 
Tuesday, June 13, 2023
Pelvic inflammatory disease, STI, Infection, QAP, Infertility, Urethritis, AMR, RUO, Buffer, Mycoplasma genitalium, OTCQX, IVD, TSX, Poster, Cervicitis, American Society for Microbiology, Society, Vaccine, MGEN

At ASM Microbe, Microbix will exhibit alongside leading firms that provide tests to diagnose and direct treatment of STIs and other infectious diseases.

Key Points: 
  • At ASM Microbe, Microbix will exhibit alongside leading firms that provide tests to diagnose and direct treatment of STIs and other infectious diseases.
  • Microbix will thereby showcase its ever-growing portfolio of QAPs that help ensure the accuracy of antigen and nucleic acid (i.e., “PCR”) tests and their workflows.
  • Using innovative and proprietary methods, Microbix created and manufactured such materials – including for five AMR variants of Mgen.
  • Formatted onto COPAN® FLOQSwabs®, the resulting Microbix QAPs were then used to validate and support novel tests for AMR detection, namely the SpeeDx Pty.

TruStage Announces Enhancements to ZoneChoice™ Registered Index-Linked Annuity

Retrieved on: 
Tuesday, June 13, 2023
Transamerica Retirement Solutions, Insurance, Life, CUNA Mutual Group, Dimensional Fund Advisors, Annuity, Retirement, Buffer, First Colony Life Insurance Company, Dimension, Life insurance, Growth

MADISON, Wis., June 13, 2023 /PRNewswire/ -- TruStage™, an insurance, investment and technology provider, announces enhancements to its ZoneChoice registered index-linked annuity (RILA). The enhancements include a new index – the Dimensional US Small Cap Value Systematic Index ("Dimensional Index") – which draws on decades of academic research to pursue higher expected returns. The Dimensional Index could also be a compelling complement to large cap market exposure, which is already available in ZoneChoice.

Key Points: 
  • MADISON, Wis., June 13, 2023 /PRNewswire/ -- TruStage™, an insurance, investment and technology provider, announces enhancements to its ZoneChoice registered index-linked annuity (RILA).
  • The Dimensional Index could also be a compelling complement to large cap market exposure, which is already available in ZoneChoice.
  • These enhancements, combined with the Dimensional Index, create more flexibility to suit each individual's risk tolerance and financial goals.
  • For more information on ZoneChoice or any of TruStage annuities, please contact the TruStage Annuities sales desk at 877.345.GROW (4769) or visit www.trustage.com/annuities .

Jackson Enhances Registered Index-Linked Annuity Suite

Retrieved on: 
Monday, June 5, 2023
Asset Management, Professional Services, Insurance, Finance, Trigger, WhiteBoard Product Solutions, MSCI EAFE, Education, Marketing, Accounting, Buffer, Rila, Ohio National Life Insurance Company, Rate center, MSCI, Retirement, JXN, Russell, MSCI KLD 400 Social Index, Cost, ESG, NYSE, Jackson National Life, Financial adviser, Life insurance, Tutoring, Index

Jackson National Life Insurance Company ® (Jackson®), the main operating subsidiary of Jackson Financial Inc.1 (NYSE: JXN), today launched Jackson Market Link Pro® II (JMLPII) and Jackson Market Link Pro Advisory® II (JMLPAII), two new registered index-linked annuities (RILAs).

Key Points: 
  • Jackson National Life Insurance Company ® (Jackson®), the main operating subsidiary of Jackson Financial Inc.1 (NYSE: JXN), today launched Jackson Market Link Pro® II (JMLPII) and Jackson Market Link Pro Advisory® II (JMLPAII), two new registered index-linked annuities (RILAs).
  • “Registered index-linked annuities are attractive investment strategies that provide flexibility, growth opportunities and partial downside protection during times of market volatility,” said Alison Reed, Chief Operating Officer of Jackson National Life Distributors LLC (JNLD), the marketing and distribution business of Jackson.
  • “Since entering the RILA market in late 2021, Jackson is committed to enhancing our suite of products to provide competitive options that seek to address clients’ unique needs.
  • In addition to the new Performance Boost crediting method4, Jackson offers two additional crediting methods — Cap and Performance Trigger.

Luis de Guindos: A resilient banking sector for the euro area

Retrieved on: 
Thursday, May 18, 2023
Gaps, Review, European Central Bank, Addition Financial, Housing, Civil service commission, Face, Fixed-rate mortgage, Communication, Wave, NPL, Shock, EBA, Common equity, Elliott District Community Government Council, Attention, Amortization, Element, Frankfurt, NPL network, Credit Suisse, EDIS, Risk, Bank, ECB, Income, Buffer, CMU, Growth, CRE, Reproduction, Environment, European Commission, Security printing, Creative industries, Management, Security (finance), Real estate, Renewable energy, Cryptocurrency, EU, Basel
Key Points: 

AM Best Affirms Credit Ratings of Dubai Insurance Company (PSC)

Retrieved on: 
Friday, May 12, 2023
Professional Services, Insurance, Finance, Pressure, DIN, AM Best, ALL, Risk management, WPP, Credit, AED, Buffer, AM, Growth, PSC, ROE, News, United Arab Emirates, Reinsurance

AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of Dubai Insurance Company (PSC) (DIN) (United Arab Emirates).

Key Points: 
  • AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of Dubai Insurance Company (PSC) (DIN) (United Arab Emirates).
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings .
  • For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments .
  • AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry.

Evox Therapeutics Presents Progress Across its DeliverEX® Platform Highlighting Advances in Exosome-Mediated Delivery of Genetic Medicines Including Gene Editing and RNA Therapeutics

Retrieved on: 
Friday, May 12, 2023
Tissue, Single, Central nervous system, EV, Gene, Intrinsic termination, Exosome, Onto Innovation, Cell, RNA, Quantification, CNS, Messenger, Small RNA, Seminal vesicles, Flow cytometry, Animal, ISEV, Buffer, Annual general meeting, American Society of Gene and Cell Therapy, RNA interference, International Society for Extracellular Vesicles, LNP, Therapy, Society, International Society, Vaccine

The six oral presentations and posters highlight the progress made in leveraging the versatility of the Company’s DeliverEX® exosome platform to deliver a wide range of genetic medicines ranging from genome editors, RNAi and mRNA as well as presenting on other exosome-related advances.

Key Points: 
  • The six oral presentations and posters highlight the progress made in leveraging the versatility of the Company’s DeliverEX® exosome platform to deliver a wide range of genetic medicines ranging from genome editors, RNAi and mRNA as well as presenting on other exosome-related advances.
  • Exosome delivery to the CNS (oral presentation): Gupta et al., provide an overview of the ability to engineer exosomes to express any desired therapeutic, including genome editors.
  • In vivo rodent data demonstrated a high degree of gene recombination after direct CNS injection using Evox’s proprietary exosome drug loading and release technology.
  • Development of exogenous loading platforms for functional targeted EV-mediated siRNA therapeutics delivery (PF09.09; poster): Levitin et al., report on progress loading of siRNA into/onto exosomes and demonstrate functional silencing activity of exosome-delivered siRNA.

NOVOSENSE at PCIM Europe 2023: Semiconductor Solutions for Automotive & Industrial Applications

Retrieved on: 
Friday, May 5, 2023
Semiconductor, Communication, Partnership, EV, Electronics, Original equipment manufacturer, Connected, Intelligence, Multimedia, Temperature, PV, Sale, Silicon carbide, Buffer, PCB, Vehicle registration plates of Nepal, BMS

From May 9 to 11, NOVOSENSE plans to showcase technologies and products for automotive and industrial applications.

Key Points: 
  • From May 9 to 11, NOVOSENSE plans to showcase technologies and products for automotive and industrial applications.
  • By means of applying innovative technologies in industrial challenges and difficulties, NOVOSENSE has been devoted to exploring industrial electronic solutions with higher integration, reliability and cost effectiveness.
  • Solutions like integrated isolated power 3CH digital isolated solution of NOVOSENSE effectively help developers simplify industrial system design.
  • See how NOVOSENSE enables automotive and industrial applications with semiconductor solutions at PCIM Europe 2023, NürnbergMesse, Karl-Schönleben-Str.

Zapata, BMW and MIT’s The Center for Quantum Engineering Publish Research On Optimizing Vehicle Production Planning Using Quantum-Inspired Generative AI Techniques

Retrieved on: 
Thursday, May 4, 2023
Semiconductor, Technology, Other Technology, Software, Networks, Artificial Intelligence, Hardware, Engineering, Computer science and engineering, Electrical engineering, Research, MIT, BMW, Science, Emerging technologies, Student, Quantum technology, GEO, Emiliano Zapata, Buffer, Algorithm, Physics, Computer science, CQE, 3D printing, Microscope

The collaboration uncovered new methods to optimize vehicle production using quantum-inspired generative AI techniques.

Key Points: 
  • The collaboration uncovered new methods to optimize vehicle production using quantum-inspired generative AI techniques.
  • Zapata and BMW’s membership in the CQE Consortium is in part to support the work of MIT students and researchers.
  • In many cases, GEO outperformed state-of-the-art solvers in minimizing assembly line idle time while maintaining monthly vehicle production targets.
  • “GEO uses quantum or quantum-inspired generative machine learning models to learn from and improve upon the results generated by classical solvers.

Teknova Launches Proprietary AAV-Tek™ Solutions Gene Therapy Product Line to Accelerate the Development of AAV Therapies

Retrieved on: 
Tuesday, May 2, 2023
Vaccine, Workflow, Research, AAV, Development, Transgene, Patient, Buffer, AEX, AAV2, Pharmaceutical industry, Fine chemical

HOLLISTER, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today launched the Company's first proprietary product line, AAV-Tek™ Solutions, specifically created to address critical pain points in the AAV gene therapy development workflow.

Key Points: 
  • HOLLISTER, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today launched the Company's first proprietary product line, AAV-Tek™ Solutions, specifically created to address critical pain points in the AAV gene therapy development workflow.
  • The first product released in this line – the AAV-Tek AEX Buffer Screening Kit – is available for purchase today and can save gene therapy developers months of process development time.
  • “Launching our first proprietary product line, AAV-Tek Solutions, is a momentous milestone and a direct result of demonstrating our team's expertise in the end-to-end AAV gene therapy workflow,” said Stephen Gunstream, Teknova’s President and Chief Executive Officer.
  • Our first product, the AAV-Tek AEX Buffer Screening Kit, was created to optimize the purification process and is one-of-a-kind in the industry.